" class="no-js "lang="en-US"> Industry News Archives - Page 89 of 151 - Medtech Alert
Friday, October 10, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Alex Therapeutics Raises €3.5M in Oversubscribed Financing round from Top Tier VC Investors to Advance Expansion in Europe and the US.

Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a €3.5M funding round, led […]

CellCentric Strengthens Leadership Team

CellCentric, a clinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, […]

Cell Guidance Systems and Manchester BIOGEL Collaborate to Launch PODS-Peptigels for 3D Cell Culture

Cell Guidance Systems Ltd, a specialist in the control, manipulation, and monitoring of cells, both in […]

Lance Baldo Joins Freenome as Chief Medical Officer

Freenome, a privately held biotech company, announced today that Lance Baldo, M.D. has joined the […]

European Healthtech Mindgram Closes €7 Million Seed Round and Begins Its European Expansion

Mindgram, the European B2B platform providing integrated support for employees in the well-being sphere, has […]

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform […]

Healthtech Company Paindrainer AB Recruits New CEO with Experience from Commercialization of Digital Services

Erik Frick is taking over as new CEO of PainDrainer AB with the task of […]

CardioRenal Raises €3.3 million

CardioRenal, a company specialized in improving treatment at home for patients with severe chronic kidney […]

Major New Review of Health Inequalities Lays Roadmap For The Role of Business in Levelling Up

A major review of health inequities published today, 4th April, lays a roadmap for the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more